TRV-120027 TFA is an angiotensin II-mediated vasoconstriction inhibitor and increases cardiomyocyte contractility. TRV-120027 TFA is a beta-arrestin-1-biased AT1R agonist engaging ß-arrestins while blocking G-protein signaling[1]. TRV-120027 TFA induces acute catecholamine secretion through cation channel subfamily C3 (TRPC3) coupling and promotes the formation of a macromolecular complex composed of AT1R-beta-arrestin-1-TRPC3-PLCgamma at the plasma membrane.
Molecular Weight:
1040.1
Purity:
97.45%
Formula:
C45H68F3N13O12
Target:
TRP/TRPV Channel|||RAAS|||Arrestin
TP2158
* VAT and and shipping costs not included. Errors and price changes excepted